Rossari Biotech discloses a rescheduling of its subsidiaries' capacity expansion project over the next two years.
The re-evaluation is due to evolving business requirements and market conditions, though the strategic intent remains.
The disclosure is made pursuant to SEBI Listing Regulations, referencing a prior intimation from April 2025.